| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | L01EK02 |
| UNII: | NQU9IPY4K9 |
| InChI Key | XXJWYDDUDKYVKI-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H27FN4O3 |
| Molecular Weight | 450.51 |
| AlogP | 5.22 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 72.5 |
| Molecular species | BASE |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Platelet-derived growth factor receptor inhibitor | PubMed |
| Primary Target | |
|---|---|
| fms related receptor tyrosine kinase 1 | |
| fms related receptor tyrosine kinase 4 | |
| kinase insert domain receptor | |
| KIT proto-oncogene, receptor tyrosine kinase | |
| platelet derived growth factor receptor alpha | |
| platelet derived growth factor receptor beta |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Glioblastoma | 3 | D005909 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Sarcoma, Alveolar Soft Part | 2 | D018234 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Biliary Tract Neoplasms | 2 | D001661 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Brain Neoplasms | 1 | D001932 | ClinicalTrials |
| Rectal Neoplasms | 1 | D012004 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Neoplasm Metastasis | 1 | D009362 | ClinicalTrials |
| Thyroid Neoplasms | 1 | D013964 | ClinicalTrials |
| Stomach Neoplasms | 1 | D013274 | ClinicalTrials |
| Peritoneal Neoplasms | 1 | D010534 | ClinicalTrials |
| Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
| Lung Neoplasms | 1 | D008175 | ClinicalTrials |
| Endometrial Neoplasms | 1 | D016889 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 288383-20-0 |
| ChEBI | 94782 |
| ChEMBL | CHEMBL491473 |
| DrugBank | DB04849 |
| EPA CompTox | DTXSID10183035 |
| FDA SRS | NQU9IPY4K9 |
| Guide to Pharmacology | 5664 |
| PubChem | 9933475 |
| SureChEMBL | SCHEMBL63147 |
| ZINC | ZINC000003948085 |